Evidence map›Paper›PMID 15975910›Full record

ArticleMolecular biology of the cell2005

GLUT1CBP(TIP2/GIPC1) interactions with GLUT1 and myosin VI: evidence supporting an adapter function for GLUT1CBP.

Brent C Reed, Christopher Cefalu, Bryan H Bellaire, James A Cardelli, Thomas Louis, Joanna Salamon, Mari Anne Bloecher, Robert C Bunn

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2.International journal of molecular sciences · 2018
    Review
  14. Article
  15. Filopodia formation and endosome clustering induced by mutant plus-end-directed myosin VI.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Article
  17. Neuropilin Functions as an Essential Cell Surface Receptor.The Journal of biological chemistry · 2015
    Review
  18. Article
  19. Article
  20. Receptor tyrosine kinases endocytosis in endothelium: biology and signaling.Arteriosclerosis, thrombosis, and vascular biology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brent C ReedDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130, USA. breed@lsuhsc.edu
Christopher Cefalu
Bryan H Bellaire
James A Cardelli
Thomas Louis
Joanna Salamon
Mari Anne Bloecher
Robert C Bunn
Louisiana State University Health Sciences Center Shreveport · USUniversity of Arkansas for Medical Sciences · US

Funding

REGULATION OF GLUCOSE TRANSPORTER TARGETING AND ACTIVITYR01DK042647 · NIDDK · LOUISIANA STATE UNIV HSC SHREVEPORT · PI REED, BRENT CLYDE · 1993 to 1995
–
NIDDK NIH HHS DK-42647
6 · The paper itself

Abstract

We identified a novel interaction between myosin VI and the GLUT1 transporter binding protein GLUT1CBP(GIPC1) and first proposed that as an adapter molecule it might function to couple vesicle-bound proteins to myosin VI movement. This study refines the model by identifying two myosin VI binding domains in the GIPC1 C terminus, assigning respective oligomerization and myosin VI binding functions to separate N- and C-terminal domains, and defining a central region in the myosin VI tail that binds GIPC1. Data further supporting the model demonstrate that 1) myosin VI and GIPC1 interactions do not require a mediating protein; 2) the myosin VI binding domain in GIPC1 is necessary for intracellular interactions of GIPC1 with myosin VI and recruitment of overexpressed myosin VI to membrane structures, but not for the association of GIPC1 with such structures; 3) GIPC1/myosin VI complexes coordinately move within cellular extensions of the cell in an actin-dependent and microtubule-independent manner; and 4) blocking either GIPC1 interactions with myosin VI or GLUT1 interactions with GIPC1 disrupts normal GLUT1 trafficking in polarized epithelial cells, leading to a reduction in the level of GLUT1 in the plasma membrane and concomitant accumulation in internal membrane structures.

Indexed as

ActinsAdaptor Proteins, Signal TransducingAnimalsCarrier ProteinsCell LineCHO CellsCricetinaeCricetulusDogsEndosomesHumansMicrotubulesMyosin Heavy ChainsNeuropeptidesProtein BindingProtein Interaction MappingActinsAdaptor Proteins, Signal TransducingCarrier ProteinsGIPC1 protein, humanMyosin Heavy Chainsmyosin VINeuropeptides

Identifiers

PMID15975910
PMCPMC1196329
OpenAlexW2107981641

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.